Cargando…

Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy

Detalles Bibliográficos
Autores principales:	DeSilva, Malini, Haapala, Jacob, Vazquez-Benitez, Gabriela, Vesco, Kimberly K., Daley, Matthew F., Getahun, Darios, Zerbo, Ousseny, Naleway, Allison, Nelson, Jennifer C., Williams, Joshua T.B., Hambidge, Simon J., Boyce, Thomas G., Fuller, Candace C., Lipkind, Heather S., Weintraub, Eric, McNeil, Michael M., Kharbanda, Elyse O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258750/ https://www.ncbi.nlm.nih.gov/pubmed/35731916 http://dx.doi.org/10.1056/NEJMc2205276

Ejemplares similares

Medically Attended Acute Adverse Events in Pregnant People After Coronavirus Disease 2019 (COVID-19) Booster Vaccination
por: DeSilva, Malini B., et al.
Publicado: (2023)

Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth — Eight Integrated Health Care Organizations, United States, December 15, 2020–July 22, 2021
por: Lipkind, Heather S., et al.
Publicado: (2022)

COVID-19 Booster Vaccination in Early Pregnancy and Surveillance for Spontaneous Abortion
por: Kharbanda, Elyse O., et al.
Publicado: (2023)

Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination
por: Naleway, Allison L., et al.
Publicado: (2021)

COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy — Eight Integrated Health Care Organizations, United States, December 14, 2020–May 8, 2021
por: Razzaghi, Hilda, et al.
Publicado: (2021)

Tdap vaccination during pregnancy and risk of chorioamnionitis and related infant outcomes
por: Greenberg, Victoria, et al.
Publicado: (2023)

1162. Influenza Vaccination Among Pregnant People in the Vaccine Safety Datalink, 2016-17 through 2022-23 Influenza Seasons
por: Irving, Stephanie, et al.
Publicado: (2023)

Association of Inadvertent 9-Valent Human Papillomavirus Vaccine in Pregnancy With Spontaneous Abortion and Adverse Birth Outcomes
por: Kharbanda, Elyse O., et al.
Publicado: (2021)

SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics — Eight U.S. Health Care Centers, March 1–May 30, 2020
por: Panagiotakopoulos, Lakshmi, et al.
Publicado: (2020)

Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination
por: Goddard, Kristin, et al.
Publicado: (2022)

Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems
por: Groom, Holly C., et al.
Publicado: (2022)

Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection
por: Tartof, Sara Y., et al.
Publicado: (2022)

COVID-19 Vaccination Coverage Among Insured Persons Aged ≥16 Years, by Race/Ethnicity and Other Selected Characteristics — Eight Integrated Health Care Organizations, United States, December 14, 2020–May 15, 2021
por: Pingali, Cassandra, et al.
Publicado: (2021)

Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic
por: Xu, Stanley, et al.
Publicado: (2022)

177. Safety of Measles and Pertussis-containing Vaccines in School-age Children Previously Diagnosed with Autism Spectrum Disorders
por: Zerbo, Ousseny, et al.
Publicado: (2020)

Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data
por: Nelson, Jennifer C, et al.
Publicado: (2022)

985. Safety of Guidelines Recommending LAIV for Routine Use in Children and Adolescents With Asthma
por: Nordin, James, et al.
Publicado: (2018)

Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August 2021
por: Grannis, Shaun J., et al.
Publicado: (2021)

2365. Effectiveness of COVID-19 Vaccines Against Medically Attended COVID-19 in Pregnant Persons Within the VISION Network, December 2021 - April 2023
por: Ciesla, Allison Avrich, et al.
Publicado: (2023)

2767. Variation in Incidence of Pediatric Herpes Zoster by First- and Second-Dose Varicella Vaccine Formulations
por: Weinmann, Sheila, et al.
Publicado: (2019)

1836. Disparities in COVID-19 Vaccination Coverage Among a Large Patient Population in a Network of Community-Based Healthcare Organizations
por: Groom, Holly C, et al.
Publicado: (2023)

Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months–5 Years — VISION Network, United States, July 2022–June 2023
por: Link-Gelles, Ruth, et al.
Publicado: (2023)

Uteroplacental bleeding disorders during pregnancy: do missing paternal characteristics influence risk?
por: Getahun, Darios, et al.
Publicado: (2006)

Temporal Trends in Chorioamnionitis by Maternal Race/Ethnicity and Gestational Age (1995–2010)
por: Fassett, Michael J., et al.
Publicado: (2013)

Tree-based data mining for safety assessment of first COVID-19 booster doses in the Vaccine Safety Datalink
por: Katherine Yih, W., et al.
Publicado: (2023)

A broad assessment of covid-19 vaccine safety using tree-based data-mining in the vaccine safety datalink
por: Yih, W. Katherine, et al.
Publicado: (2023)

Safety of measles, mumps, and rubella vaccine in adolescents and adults in the vaccine safety Datalink
por: Hanson, Kayla E., et al.
Publicado: (2023)

Birth and early developmental screening outcomes associated with cannabis exposure during pregnancy
por: Kharbanda, Elyse Olshen, et al.
Publicado: (2020)

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022
por: Tenforde, Mark W., et al.
Publicado: (2022)

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022
por: Tenforde, Mark W., et al.
Publicado: (2023)

2766. Identification and Description of Mumps Cases in a Non-Outbreak Setting and Evaluation of the Effectiveness of Mumps Containing Vaccines Over Time
por: Zerbo, Ousseny, et al.
Publicado: (2019)

2297. COVID-19 Vaccine Effectiveness Among Pregnant People
por: Zerbo, Ousseny, et al.
Publicado: (2022)

Polychlorinated Biphenyl and Organochlorine Pesticide Concentrations in Maternal Mid-Pregnancy Serum Samples: Association with Autism Spectrum Disorder and Intellectual Disability
por: Lyall, Kristen, et al.
Publicado: (2016)

Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings
por: Thompson, Mark G., et al.
Publicado: (2021)

2275. Parental Risk Factors for Fever in their Children 7–10 Days After the First Dose of Measles-Containing Vaccines
por: Zerbo, Ousseny, et al.
Publicado: (2018)

Parental risk factors for fever in their children 7–10 days after the first dose of measles-containing vaccines
por: Zerbo, Ousseny, et al.
Publicado: (2019)

Extended surveillance to assess safety of 9-valent human papillomavirus vaccine
por: Sundaram, Maria E., et al.
Publicado: (2022)

Effectiveness of COVID-19 Vaccines at Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompromised Adults: An Observational Study of Real-World Data Across 10 US States from August-December 2021
por: Embi, Peter J., et al.
Publicado: (2023)

Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data()
por: DeSilva, Malini, et al.
Publicado: (2016)

Identification and description of mumps cases in a non-outbreak setting and evaluation of the effectiveness of mumps-containing vaccines over time
por: Zerbo, Ousseny, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dnjne76p3cf92ervf294b8n2qe